The study was designed to compare effectiveness and safety of the surgeries of Ivor-Lewis and Mckeown in patients with esophageal cancer

The trial is a multi-centre real-world non-interventional observational study. The study was designed to compare effectiveness and safety of the minimally invasive surgeries of Ivor-Lewis and Mckeown in the Chinese patients with IA-IIIB esophageal cancer via a retrospectively review method based on the study data on patient demographic/tumor biological characteristics and clinical treatments.

Inclusion Criteria:

• Pathologically diagnosed middle and lower thoracic IA-IIIB esophageal cancer after surgeries;
• Patients who received minimally invasive radical dissections of Ivor-Lewis and Mckeown;
• Patients who received tubular gastroesophageal reconstruction;

Exclusion Criteria:

• Patients complicated with arrhythmia, or serious disfunctions of heart, lung, liver, and kidney before surgeries;
• Patients with second primary tumors;
• Patients who received abdominal or thoracic surgeries;
• Patients who received gastrostomy or nesteostomy before surgeries;
• Patients with suspected cervical lymph metastases (in the subgroup of the patients who received the surgery of Mckeown)

Pathogically diagnosed IA-IIIB patients with esophageal cancer who received the surgeries of Ivor-Lewis and Mckeown